Project Details
Description
A double-blind, randomized, vehicle controlled, crossover study to evaluate the safety and efficacy of topical naloxone hydrochloride lotion, 0.5%, for the relief of pruritus in patients with the mycfungoides (MF) form of cutaneous t-cell lymphoma (CTCL)
| Status | Active |
|---|---|
| Effective start/end date | 10/1/17 → 2/20/24 |
Funding
- ELORAC INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.